1. Home
  2. BBCP vs SLN Comparison

BBCP vs SLN Comparison

Compare BBCP & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBCP
  • SLN
  • Stock Information
  • Founded
  • BBCP 1983
  • SLN 1994
  • Country
  • BBCP United States
  • SLN United Kingdom
  • Employees
  • BBCP N/A
  • SLN N/A
  • Industry
  • BBCP Engineering & Construction
  • SLN Biotechnology: Pharmaceutical Preparations
  • Sector
  • BBCP Consumer Discretionary
  • SLN Health Care
  • Exchange
  • BBCP Nasdaq
  • SLN Nasdaq
  • Market Cap
  • BBCP 370.5M
  • SLN 352.2M
  • IPO Year
  • BBCP 2017
  • SLN N/A
  • Fundamental
  • Price
  • BBCP $8.98
  • SLN $5.56
  • Analyst Decision
  • BBCP Buy
  • SLN Strong Buy
  • Analyst Count
  • BBCP 4
  • SLN 4
  • Target Price
  • BBCP $7.67
  • SLN $61.50
  • AVG Volume (30 Days)
  • BBCP 149.2K
  • SLN 439.4K
  • Earning Date
  • BBCP 01-08-2025
  • SLN 03-11-2025
  • Dividend Yield
  • BBCP N/A
  • SLN N/A
  • EPS Growth
  • BBCP N/A
  • SLN N/A
  • EPS
  • BBCP 0.26
  • SLN N/A
  • Revenue
  • BBCP $425,872,000.00
  • SLN $21,773,221.00
  • Revenue This Year
  • BBCP $1.64
  • SLN N/A
  • Revenue Next Year
  • BBCP $5.84
  • SLN $104.98
  • P/E Ratio
  • BBCP $34.02
  • SLN N/A
  • Revenue Growth
  • BBCP N/A
  • SLN N/A
  • 52 Week Low
  • BBCP $5.05
  • SLN $4.82
  • 52 Week High
  • BBCP $9.68
  • SLN $27.72
  • Technical
  • Relative Strength Index (RSI)
  • BBCP 77.06
  • SLN 33.35
  • Support Level
  • BBCP $6.46
  • SLN $4.82
  • Resistance Level
  • BBCP $9.68
  • SLN $7.87
  • Average True Range (ATR)
  • BBCP 0.44
  • SLN 0.65
  • MACD
  • BBCP 0.23
  • SLN 0.02
  • Stochastic Oscillator
  • BBCP 78.90
  • SLN 22.70

About BBCP Concrete Pumping Holdings Inc.

Concrete Pumping Holdings Inc is a provider of concrete pumping services and concrete waste management services in the fragmented United States and United Kingdom markets. Its large fleet of specialized pumping equipment and trained operators position it to deliver concrete placement solutions. The company's operating segment includes U.S. Concrete Pumping; U.K. Operations; U.S. Concrete Waste Management Services and Corporate. It generates maximum revenue from the U.S. Concrete Pumping segment. Geographically, it generates majority of the revenue from its business in United States.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid. its pipeline products are; SLN360 therapy designed to temporarily block a specific gene's message that would otherwise trigger an unwanted effect. By silencing the LPA gene, the levels of Lp(a) are lowered, which in turn is expected to lower the risks of heart diseases, heart attacks, and strokes, and SLN124 therapy aims to temporarily silence TMPRSS6, a gene that prevents the liver from producing a particular hormone that controls iron levels in the body hepcidin. As hepcidin increases, iron levels in the blood are expected to decrease, which may increase the production of healthy red blood cells, thereby reducing anemia.

Share on Social Networks: